The Medical Group Management Association offers an analysis of pending legislation that could help health care practices better serve patients.
This article originally appeared on Medical Economics®.
Medicare cuts are coming and that’s bad news for physicians, but there is still time for federal lawmakers to act.
The Medical Group Management Association (MGMA) submitted its policy analysis on Medicare in comments for the House Committee on Energy & Commerce. The committee’s Subcommittee on Health has been meeting this month to discuss pending legislation, pressing issues in health care, and how federal regulations are affecting physicians, patients, and the health care sector.
Debate and testimony started in the hearing “What’s the Prognosis? Examining Medicare Proposals to Improve Patient Access to Care & Minimize Red Tape for Doctors.” MGMA Senior Vice President-Government Affairs Anders Gilberg submitted written comments for that hearing.
Anders Gilberg, senior vice president-government affairs, Medical Group Management Association
“While MGMA is supportive of a fiscally responsible Medicare system that puts patients first, we remain concerned that current policies place unnecessary administrative burdens on medical groups, thus impacting access to care,” said the letter from Gilberg to subcommittee Chair Representative Brett Guthrie, R-Kentucky, and Ranking Member Representative Anna Eshoo, D-California.
Next year could bring a 3.36% cut in the conversion factor, as proposed by CMS. Congress needs to work stop that, Gilberg said. From 2001 to 2023, Medicare physician payment has effectively decreased by 26% when adjusted for inflation, he said.
An alternative is in the bill known as the “Strengthening Medicare for Patients and Providers Act.” It would create a yearly Medicare physician payment update tied to inflation, based on the Medicare Economic Index, Gilberg said.
“Addressing the proposed conversion factor cut and providing sustainable reimbursement will allow medical groups to thrive and focus on providing high-quality care,” he said in the letter.
Bills That Could Help
MGMA members were nearly unanimous (97%) agreeing fewer regulatory burdens would allow them to dedicate more resources to patient care. MGMA is endorsing additional legislation to change health care for the better.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More